Do you want to read an article? Please log in or register.
Association of Metabolomics With Incidence of Age-Related Macular Degeneration: The UK Biobank Study
Macular Diseases
Related content
Macular DiseasesFurther Publications
Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank
Invest Ophthalmol Vis Sci
Peng Y, Zhang Y, Kam KW, Wong G, Ho M, Sezto S, Au S, Zhang X, Ng MPH, Ip P, Young A, Pang CP, Tham CC, Chen LJ, Yam JC
doi: 10.1167/iovs.66.4.63
Macular Diseases
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Br J Ophthalmol
Vu TA, Fenwick EK, Man REK, Thakur S, Tan ACS, Cheung CMG, Gupta P, Lamoureux EL
doi: 10.1136/bjo-2024-325713
COMMENTED
Macular DiseasesRetinal Diseases
Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Lee MY, Han K, Min KH, Yu DS, Lee YB
doi: 10.1016/j.ajo.2024.08.033
Macular Diseases
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmol Ther
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V, Fight Retinal Blindness! Study Group
doi: 10.1007/s40123-024-00983-2
COMMENTED
Glaucoma and Ocular PressureMacular Diseases
Disease Associations among Patients Afflicted with Both Glaucoma and Age-Related Macular Degeneration
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
J Clin Med
Dimalanta L, Pithadia K, Shenkute NT, Strelow B, Zhang Z, Ulrich J, Zhang AY, Fleischman D
doi: 10.3390/jcm13195941
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
Br J Ophthalmol
Borrelli E, Foti C, Ulla L, Porreca A, Introini U, Grassi MO, Viggiano P, Peronetti M, Toscani R, Boscia G, Termite AC, Gennaro C, Marolo P, Boscia F, Bandello F, Reibaldi M
doi: 10.1136/bjo-2024-326152
Macular Diseases
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration
J Clin Med
Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group
doi: 10.3390/jcm14072370
Macular Diseases
Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
Int J Retina Vitreous
Grimaldi G, Cancian G, Paris A, Clerici M, Volpe G, Menghini M
doi: 10.1186/s40942-024-00586-w